tiprankstipranks
Trending News
More News >
Roche Holding (CH:ROG)
:ROG
Switzerland Market
Advertisement

Roche Holding AG (ROG) Stock Forecast & Price Target

Compare
21 Followers
See the Price Targets and Ratings of:

ROG Analyst Ratings

Hold
11Ratings
Hold
4 Buy
4 Hold
3 Sell
Based on 11 analysts giving stock ratings to
Roche
Holding AG
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ROG Stock 12 Month Forecast

Average Price Target

CHF280.20
▲(8.10%Upside)
Based on 11 Wall Street analysts offering 12 month price targets for Roche Holding AG in the last 3 months. The average price target is CHF280.20 with a high forecast of CHF345.00 and a low forecast of CHF230.00. The average price target represents a 8.10% change from the last price of CHF259.20.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"229":"CHF229","258":"CHF258","287":"CHF287","316":"CHF316","345":"CHF345"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":344.9973565225,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF345.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":280.1984117565,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF280.20</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":230.0009148815,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF230.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[229,258,287,316,345],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,260.7,267.1844120401923,273.6688240803846,280.15323612057693,286.63764816076923,293.1220602009615,299.6064722411538,306.0908842813462,312.5752963215385,319.05970836173077,325.54412040192307,332.0285324421154,338.5129444823077,{"y":344.9973565225,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,260.7,262.19987782742305,263.6997556548461,265.19963348226923,266.6995113096923,268.19938913711536,269.6992669645384,271.19914479196154,272.6990226193846,274.19890044680767,275.69877827423073,277.19865610165385,278.6985339290769,{"y":280.1984117565,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,260.7,258.3385319139615,255.97706382792308,253.61559574188462,251.25412765584613,248.89265956980768,246.53119148376922,244.16972339773076,241.8082553116923,239.44678722565385,237.08531913961536,234.7238510535769,232.36238296753845,{"y":230.0009148815,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":242.093,"date":1719792000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 29, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 13</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":276.65,"date":1722470400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 13</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":278.489,"date":1725148800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 18</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":256.516,"date":1727740800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 16</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":264.357,"date":1730419200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 17</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":247.998,"date":1733011200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 13</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":247.32,"date":1735689600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 15</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":276.844,"date":1738368000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 19</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":289.621,"date":1740787200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 18</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":292.4,"date":1743465600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 18</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":269.3,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 14</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":264.7,"date":1748736000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 15</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":260.7,"date":1751328000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 16</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetCHF345.00Average Price TargetCHF280.20Lowest Price TargetCHF230.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on CH:ROG
TipRanks AITipRanks
Not Ranked
TipRanks
CHF288
Buy
11.11%
Upside
Reiterated
07/29/25
Roche's overall stock score reflects its solid financial performance, driven primarily by strong cash flow and effective cost management. The positive sentiment from the recent earnings call further boosts confidence, particularly with new product approvals and pipeline expansion. Technical analysis presents some caution with bearish momentum indicators, while valuation is slightly high but supported by a strong dividend yield. Despite challenges in certain segments, Roche's strategic growth drivers and financial stability position it well in the industry.
UBS
CHF314
Buy
21.14%
Upside
Reiterated
07/28/25
Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (NASDAQ: SRPT) and Roche Holding AG (Other OTC: RHHVF)
J.P. Morgan Analyst forecast on CH:ROG
Richard VosserJ.P. Morgan
J.P. Morgan
CHF220CHF230
Sell
-11.27%
Downside
Reiterated
07/28/25
J.P. Morgan Keeps Their Sell Rating on Roche Holding AG (RHHVF)
Barclays Analyst forecast on CH:ROG
Emily FieldBarclays
Barclays
CHF275
Hold
6.10%
Upside
Reiterated
07/28/25
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF) and Lonza Group (Other OTC: LZAGY)
Goldman Sachs Analyst forecast on CH:ROG
James QuigleyGoldman Sachs
Goldman Sachs
CHF246CHF242
Sell
-6.64%
Downside
Reiterated
07/28/25
Goldman Sachs Reaffirms Their Sell Rating on Roche Holding AG (RHHVF)
DZ BANK AG Analyst forecast on CH:ROG
Elmar KrausDZ BANK AG
DZ BANK AG
Buy
Reiterated
07/25/25
DZ BANK AG Reaffirms Their Buy Rating on Roche Holding AG (RHHVF)
Bernstein Analyst forecast on CH:ROG
Justin SmithBernstein
Bernstein
CHF345
Buy
33.10%
Upside
Reiterated
07/24/25
Bernstein Sticks to Their Buy Rating for Roche Holding AG (RHHVF)
Jefferies
CHF270
Hold
4.17%
Upside
Reiterated
07/24/25
Analysts Conflicted on These Healthcare Names: Roche Holding AG (Other OTC: RHHVF) and Thermo Fisher (NYSE: TMO)
Kepler Capital  Analyst forecast on CH:ROG
David EvansKepler Capital
Kepler Capital
CHF315
Buy
21.53%
Upside
Reiterated
07/24/25
Kepler Capital Sticks to Its Buy Rating for Roche Holding AG (RHHVF)
Morgan Stanley Analyst forecast on CH:ROG
Sarita KapilaMorgan Stanley
Morgan Stanley
CHF286
Hold
10.34%
Upside
Reiterated
07/24/25
Roche Holding AG: Hold Rating Amid Mixed Financial Signals and Strategic Challenges
Deutsche Bank  Analyst forecast on CH:ROG
Emmanuel PapadakisDeutsche Bank
Deutsche Bank
CHF235
Sell
-9.34%
Downside
Reiterated
07/22/25
Deutsche Bank Reaffirms Their Sell Rating on Roche Holding AG (RHHVF)
Berenberg Bank Analyst forecast on CH:ROG
Luisa HectorBerenberg Bank
Berenberg Bank
CHF290
Hold
11.88%
Upside
Reiterated
07/17/25
Berenberg Bank Remains a Hold on Roche Holding AG (RHHVF)
HSBC
CHF338CHF295
Hold
13.81%
Upside
Downgraded
04/28/25
Roche downgraded to Hold from Buy at HSBCRoche downgraded to Hold from Buy at HSBC
Exane BNP Paribas Analyst forecast on CH:ROG
Peter VerdultExane BNP Paribas
Exane BNP Paribas
CHF300
Buy
15.74%
Upside
Initiated
04/16/25
BNP Paribas Exane Starts Roche Holding (ROG:SW) (RHHBY) at OutperformBNP Paribas Exane analyst Peter Verdult initiates coverage on Roche Holding (ROG:SW) (OTC: RHHBY) with a Outperform rating and a price target of CHF300.00.
Erste Group Analyst forecast on CH:ROG
Hans EngelErste Group
Erste Group
Hold
Downgraded
11/05/24
Erste Group Downgrades Roche Holding (ROG:SW) (RHHBY) to HoldErste Group analyst Hans Engel downgraded Roche Holding (ROG:SW) (OTC: RHHBY) from Buy to Hold.
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on CH:ROG
TipRanks AITipRanks
Not Ranked
TipRanks
CHF288
Buy
11.11%
Upside
Reiterated
07/29/25
Roche's overall stock score reflects its solid financial performance, driven primarily by strong cash flow and effective cost management. The positive sentiment from the recent earnings call further boosts confidence, particularly with new product approvals and pipeline expansion. Technical analysis presents some caution with bearish momentum indicators, while valuation is slightly high but supported by a strong dividend yield. Despite challenges in certain segments, Roche's strategic growth drivers and financial stability position it well in the industry.
UBS
CHF314
Buy
21.14%
Upside
Reiterated
07/28/25
Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (NASDAQ: SRPT) and Roche Holding AG (Other OTC: RHHVF)
J.P. Morgan Analyst forecast on CH:ROG
Richard VosserJ.P. Morgan
J.P. Morgan
CHF220CHF230
Sell
-11.27%
Downside
Reiterated
07/28/25
J.P. Morgan Keeps Their Sell Rating on Roche Holding AG (RHHVF)
Barclays Analyst forecast on CH:ROG
Emily FieldBarclays
Barclays
CHF275
Hold
6.10%
Upside
Reiterated
07/28/25
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF) and Lonza Group (Other OTC: LZAGY)
Goldman Sachs Analyst forecast on CH:ROG
James QuigleyGoldman Sachs
Goldman Sachs
CHF246CHF242
Sell
-6.64%
Downside
Reiterated
07/28/25
Goldman Sachs Reaffirms Their Sell Rating on Roche Holding AG (RHHVF)
DZ BANK AG Analyst forecast on CH:ROG
Elmar KrausDZ BANK AG
DZ BANK AG
Buy
Reiterated
07/25/25
DZ BANK AG Reaffirms Their Buy Rating on Roche Holding AG (RHHVF)
Bernstein Analyst forecast on CH:ROG
Justin SmithBernstein
Bernstein
CHF345
Buy
33.10%
Upside
Reiterated
07/24/25
Bernstein Sticks to Their Buy Rating for Roche Holding AG (RHHVF)
Jefferies
CHF270
Hold
4.17%
Upside
Reiterated
07/24/25
Analysts Conflicted on These Healthcare Names: Roche Holding AG (Other OTC: RHHVF) and Thermo Fisher (NYSE: TMO)
Kepler Capital  Analyst forecast on CH:ROG
David EvansKepler Capital
Kepler Capital
CHF315
Buy
21.53%
Upside
Reiterated
07/24/25
Kepler Capital Sticks to Its Buy Rating for Roche Holding AG (RHHVF)
Morgan Stanley Analyst forecast on CH:ROG
Sarita KapilaMorgan Stanley
Morgan Stanley
CHF286
Hold
10.34%
Upside
Reiterated
07/24/25
Roche Holding AG: Hold Rating Amid Mixed Financial Signals and Strategic Challenges
Deutsche Bank  Analyst forecast on CH:ROG
Emmanuel PapadakisDeutsche Bank
Deutsche Bank
CHF235
Sell
-9.34%
Downside
Reiterated
07/22/25
Deutsche Bank Reaffirms Their Sell Rating on Roche Holding AG (RHHVF)
Berenberg Bank Analyst forecast on CH:ROG
Luisa HectorBerenberg Bank
Berenberg Bank
CHF290
Hold
11.88%
Upside
Reiterated
07/17/25
Berenberg Bank Remains a Hold on Roche Holding AG (RHHVF)
HSBC
CHF338CHF295
Hold
13.81%
Upside
Downgraded
04/28/25
Roche downgraded to Hold from Buy at HSBCRoche downgraded to Hold from Buy at HSBC
Exane BNP Paribas Analyst forecast on CH:ROG
Peter VerdultExane BNP Paribas
Exane BNP Paribas
CHF300
Buy
15.74%
Upside
Initiated
04/16/25
BNP Paribas Exane Starts Roche Holding (ROG:SW) (RHHBY) at OutperformBNP Paribas Exane analyst Peter Verdult initiates coverage on Roche Holding (ROG:SW) (OTC: RHHBY) with a Outperform rating and a price target of CHF300.00.
Erste Group Analyst forecast on CH:ROG
Hans EngelErste Group
Erste Group
Hold
Downgraded
11/05/24
Erste Group Downgrades Roche Holding (ROG:SW) (RHHBY) to HoldErste Group analyst Hans Engel downgraded Roche Holding (ROG:SW) (OTC: RHHBY) from Buy to Hold.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Roche Holding AG

1 Month
xxx
Success Rate
32/57 ratings generated profit
56%
Average Return
+0.99%
reiterated a xxx
rating 9 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 56.14% of your transactions generating a profit, with an average return of +0.99% per trade.
3 Months
xxx
Success Rate
33/50 ratings generated profit
66%
Average Return
+1.31%
reiterated a xxx
rating 3 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.00% of your transactions generating a profit, with an average return of +1.31% per trade.
1 Year
Richard VosserJ.P. Morgan
Success Rate
27/50 ratings generated profit
54%
Average Return
+1.55%
reiterated a sell rating 3 days ago
Copying Richard Vosser's trades and holding each position for 1 Year would result in 54.00% of your transactions generating a profit, with an average return of +1.55% per trade.
2 Years
xxx
Success Rate
32/57 ratings generated profit
56%
Average Return
+4.70%
reiterated a xxx
rating 9 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 56.14% of your transactions generating a profit, with an average return of +4.70% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ROG Analyst Recommendation Trends

Rating
Mar 25
Apr 25
May 25
Jun 25
Jul 25
Strong Buy
0
0
0
0
0
Buy
12
17
17
16
19
Hold
8
10
11
12
11
Sell
18
18
14
15
16
Strong Sell
0
0
0
0
0
total
38
45
42
43
46
In the current month, ROG has received 19 Buy Ratings, 11 Hold Ratings, and 16 Sell Ratings. ROG average Analyst price target in the past 3 months is 280.20.
Each month's total comprises the sum of three months' worth of ratings.

ROG Financial Forecast

ROG Earnings Forecast

Next quarter’s earnings estimate for ROG is CHF9.27 with a range of CHF8.50 to CHF10.67. The previous quarter’s EPS was CHF11.08. ROG beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 38.43% of the time in the same period. In the last calendar year ROG has Outperformed its overall industry.
Next quarter’s earnings estimate for ROG is CHF9.27 with a range of CHF8.50 to CHF10.67. The previous quarter’s EPS was CHF11.08. ROG beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 38.43% of the time in the same period. In the last calendar year ROG has Outperformed its overall industry.

ROG Sales Forecast

Next quarter’s sales forecast for ROG is CHF31.61B with a range of CHF31.00B to CHF32.41B. The previous quarter’s sales results were CHF30.94B. ROG beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 49.11% of the time in the same period. In the last calendar year ROG has Outperformed its overall industry.
Next quarter’s sales forecast for ROG is CHF31.61B with a range of CHF31.00B to CHF32.41B. The previous quarter’s sales results were CHF30.94B. ROG beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 49.11% of the time in the same period. In the last calendar year ROG has Outperformed its overall industry.

ROG Stock Forecast FAQ

What is CH:ROG’s average 12-month price target, according to analysts?
Based on analyst ratings, Roche Holding’s 12-month average price target is 280.20.
    What is CH:ROG’s upside potential, based on the analysts’ average price target?
    Roche Holding has 8.10% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Roche Holding a Buy, Sell or Hold?
          Roche Holding has a consensus rating of Hold, which is based on 4 buy ratings, 4 hold ratings and 3 sell ratings.
            What is Roche Holding’s share price target?
            The average share price target for Roche Holding is 280.20. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is CHF345.00 ,and the lowest forecast is CHF230.00. The average share price target represents 8.10% Increase from the current price of CHF259.2.
              What do analysts say about Roche Holding?
              Roche Holding’s analyst rating consensus is a Hold. This is based on the ratings of 11 Wall Streets Analysts.
                How can I buy shares of Roche Holding?
                To buy shares of CH:ROG, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis